TP53 and breast cancer: Based on this single criterion, only 2/82 breast cancer patients <40 (2.5%) had a germline TP53 pathogenic variant, 1/132 aged ≤40 and among women without a known family history consistent with Chompret criteria, TP53 variants were found in only 1/195 (0.5%).